JP2013536179A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013536179A5 JP2013536179A5 JP2013521954A JP2013521954A JP2013536179A5 JP 2013536179 A5 JP2013536179 A5 JP 2013536179A5 JP 2013521954 A JP2013521954 A JP 2013521954A JP 2013521954 A JP2013521954 A JP 2013521954A JP 2013536179 A5 JP2013536179 A5 JP 2013536179A5
- Authority
- JP
- Japan
- Prior art keywords
- ylamino
- benzo
- oxazol
- methyl
- pyrimidin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 -CF Three Chemical group 0.000 description 68
- 150000001875 compounds Chemical class 0.000 description 28
- 125000000217 alkyl group Chemical group 0.000 description 27
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 26
- 238000000034 method Methods 0.000 description 24
- 125000005605 benzo group Chemical group 0.000 description 18
- 125000004429 atom Chemical group 0.000 description 11
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 10
- 125000003118 aryl group Chemical group 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 125000005843 halogen group Chemical group 0.000 description 8
- 239000008194 pharmaceutical composition Substances 0.000 description 8
- ASSKVPFEZFQQNQ-UHFFFAOYSA-N 2-benzoxazolinone Chemical compound C1=CC=C2OC(O)=NC2=C1 ASSKVPFEZFQQNQ-UHFFFAOYSA-N 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 description 6
- 125000003710 aryl alkyl group Chemical group 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 125000000753 cycloalkyl group Chemical group 0.000 description 6
- 125000001072 heteroaryl group Chemical group 0.000 description 6
- 125000005842 heteroatom Chemical group 0.000 description 6
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 6
- 102000042838 JAK family Human genes 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- ITDXRIFHDJKTAA-UHFFFAOYSA-N 3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC=C2OC(=O)NC2=C1 ITDXRIFHDJKTAA-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 4
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 4
- 125000002619 bicyclic group Chemical group 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 125000004404 heteroalkyl group Chemical group 0.000 description 4
- 125000004446 heteroarylalkyl group Chemical group 0.000 description 4
- 125000002950 monocyclic group Chemical group 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 208000023275 Autoimmune disease Diseases 0.000 description 3
- 125000001313 C5-C10 heteroaryl group Chemical group 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- XQCZBXHVTFVIFE-UHFFFAOYSA-N 2-amino-4-hydroxypyrimidine Chemical compound NC1=NC=CC(O)=N1 XQCZBXHVTFVIFE-UHFFFAOYSA-N 0.000 description 2
- QKHQEETZGJUPOR-UHFFFAOYSA-N 2-methoxy-6-methyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzoic acid Chemical compound CC1=C(C(O)=O)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 QKHQEETZGJUPOR-UHFFFAOYSA-N 0.000 description 2
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 2
- BVMWIXWOIGJRGE-UHFFFAOYSA-N NP(O)=O Chemical group NP(O)=O BVMWIXWOIGJRGE-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 229910052805 deuterium Inorganic materials 0.000 description 2
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 125000005241 heteroarylamino group Chemical group 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- CQQBUBUDFYGWFV-UHFFFAOYSA-N 2,6-dimethyl-4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(C)=C(C#N)C(C)=C1 CQQBUBUDFYGWFV-UHFFFAOYSA-N 0.000 description 1
- HMHIINMUADBISS-UHFFFAOYSA-N 2-[4-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]phenyl]acetaldehyde Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(CC=O)C=C1 HMHIINMUADBISS-UHFFFAOYSA-N 0.000 description 1
- XKJMNBXQXFINKX-UHFFFAOYSA-N 2-fluoro-3-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]benzonitrile;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(C#N)=C1F XKJMNBXQXFINKX-UHFFFAOYSA-N 0.000 description 1
- BLOBGYACHNZQHW-UHFFFAOYSA-N 2-methyl-6-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridine-3-carbonitrile Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(C#N)C(C)=N1 BLOBGYACHNZQHW-UHFFFAOYSA-N 0.000 description 1
- PEWAIWRUUGVRFE-UHFFFAOYSA-N 3-[[5-chloro-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-2-fluorobenzonitrile;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC=C(C#N)C(F)=C1NC1=NC=C(Cl)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 PEWAIWRUUGVRFE-UHFFFAOYSA-N 0.000 description 1
- IANOZUTZODAJSM-UHFFFAOYSA-N 3-methyl-5-[[5-methyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4N(C)C(=O)OC4=CC=3)C(C)=CN=2)=C1 IANOZUTZODAJSM-UHFFFAOYSA-N 0.000 description 1
- NZVKTUYSHCWKCL-UHFFFAOYSA-N 3h-1,3-oxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound O=C1NC=CO1.OC(=O)C(F)(F)F NZVKTUYSHCWKCL-UHFFFAOYSA-N 0.000 description 1
- KCUSGANGRWSONG-UHFFFAOYSA-N 4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]-2-(3,4,5-trimethylanilino)pyrimidine-5-carboxylic acid;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C(O)=O)=CN=2)=C1 KCUSGANGRWSONG-UHFFFAOYSA-N 0.000 description 1
- TZBLQBRLXLNABA-UHFFFAOYSA-N 4-[[5-fluoro-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-2,6-dimethylbenzonitrile Chemical compound CC1=C(C#N)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 TZBLQBRLXLNABA-UHFFFAOYSA-N 0.000 description 1
- ICIDGNQYUIUUBW-UHFFFAOYSA-N 4-[[5-fluoro-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-n-propan-2-ylbenzamide;formic acid Chemical compound OC=O.C1=CC(C(=O)NC(C)C)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ICIDGNQYUIUUBW-UHFFFAOYSA-N 0.000 description 1
- ZRTGMWRBMGQKKE-UHFFFAOYSA-N 4-methyl-6-[[5-methyl-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]pyridine-3-carbonitrile Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(C)=C(C#N)C=N1 ZRTGMWRBMGQKKE-UHFFFAOYSA-N 0.000 description 1
- YLLIKDNBCSMBDD-UHFFFAOYSA-N 5-[(2-amino-5-fluoro-6-phenylpyrimidin-4-yl)amino]-3H-1,3-benzoxazol-2-one Chemical compound C1(=CC=CC=C1)C1=C(C(=NC(=N1)N)NC=1C=CC2=C(NC(O2)=O)C=1)F YLLIKDNBCSMBDD-UHFFFAOYSA-N 0.000 description 1
- BOKOUDYMWNXLGH-UHFFFAOYSA-N 5-[(2-anilino-5-chloropyrimidin-4-yl)amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(Cl)=CN=C1NC1=CC=CC=C1 BOKOUDYMWNXLGH-UHFFFAOYSA-N 0.000 description 1
- BLKCWNVNVANBHP-UHFFFAOYSA-N 5-[(2-anilino-5-nitropyrimidin-4-yl)amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C([N+](=O)[O-])=CN=C1NC1=CC=CC=C1 BLKCWNVNVANBHP-UHFFFAOYSA-N 0.000 description 1
- LPHCLCMKBSJBDO-UHFFFAOYSA-N 5-[[2-(1,3-dihydro-2-benzofuran-5-ylamino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4COCC4=CC=3)=NC=C2C)=C1 LPHCLCMKBSJBDO-UHFFFAOYSA-N 0.000 description 1
- DIKGXTRGYVCEIP-UHFFFAOYSA-N 5-[[2-(2,4-difluoro-3-methoxyanilino)-5-fluoropyrimidin-4-yl]amino]-7-fluoro-3h-1,3-benzoxazol-2-one Chemical compound COC1=C(F)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(F)=CN=2)=C1F DIKGXTRGYVCEIP-UHFFFAOYSA-N 0.000 description 1
- AYPFNIHHENCZOS-UHFFFAOYSA-N 5-[[2-(2,4-difluoro-3-methoxyanilino)-5-fluoropyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=C(F)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(F)=CN=2)=C1F AYPFNIHHENCZOS-UHFFFAOYSA-N 0.000 description 1
- BROZPOZIIOBNNZ-UHFFFAOYSA-N 5-[[2-(2,4-difluoro-3-methoxyanilino)-5-nitropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=C(F)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(=CN=2)[N+]([O-])=O)=C1F BROZPOZIIOBNNZ-UHFFFAOYSA-N 0.000 description 1
- HWOSGLSHLHGNBR-UHFFFAOYSA-N 5-[[2-(2,4-difluoro-3-propan-2-yloxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC(C)OC1=C(F)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1F HWOSGLSHLHGNBR-UHFFFAOYSA-N 0.000 description 1
- WQMZENQZLBGFSR-UHFFFAOYSA-N 5-[[2-(2-fluoro-3,4-dimethoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC1=C(OC)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 WQMZENQZLBGFSR-UHFFFAOYSA-N 0.000 description 1
- VYAOXGKPFCICGJ-UHFFFAOYSA-N 5-[[2-(2-fluoro-3-methoxy-4-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=C(C)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1F VYAOXGKPFCICGJ-UHFFFAOYSA-N 0.000 description 1
- OKSYUCSOWVGFFQ-UHFFFAOYSA-N 5-[[2-(2-fluoro-3-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1F OKSYUCSOWVGFFQ-UHFFFAOYSA-N 0.000 description 1
- KSCNGRQEMCGODB-UHFFFAOYSA-N 5-[[2-(2-fluoro-3-methoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C=CN=2)=C1F KSCNGRQEMCGODB-UHFFFAOYSA-N 0.000 description 1
- GVJPNCTVCUNHMF-UHFFFAOYSA-N 5-[[2-(2-fluoro-4-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=CC(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 GVJPNCTVCUNHMF-UHFFFAOYSA-N 0.000 description 1
- WKJGVCNCTBQCBE-UHFFFAOYSA-N 5-[[2-(2-fluoro-5-methoxy-4-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1F WKJGVCNCTBQCBE-UHFFFAOYSA-N 0.000 description 1
- NEMMTUDMKUIEIH-UHFFFAOYSA-N 5-[[2-(3,4-diethoxy-2-fluoroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC1=C(OCC)C(OCC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 NEMMTUDMKUIEIH-UHFFFAOYSA-N 0.000 description 1
- HUWBZBKNHFFQRB-UHFFFAOYSA-N 5-[[2-(3,4-dimethoxy-5-methylanilino)-5-fluoropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 HUWBZBKNHFFQRB-UHFFFAOYSA-N 0.000 description 1
- BNESUYMLWRMWOQ-UHFFFAOYSA-N 5-[[2-(3,4-dimethoxy-5-methylanilino)-5-fluoropyrimidin-4-yl]amino]-7-fluoro-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(F)=CN=2)=C1 BNESUYMLWRMWOQ-UHFFFAOYSA-N 0.000 description 1
- KEDJNSAGZCTYBO-UHFFFAOYSA-N 5-[[2-(3,4-dimethoxy-5-methylanilino)-5-fluoropyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(F)=CN=2)=C1 KEDJNSAGZCTYBO-UHFFFAOYSA-N 0.000 description 1
- JMQUFKAINVANSW-UHFFFAOYSA-N 5-[[2-(3,5-difluoroanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=CC(F)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C=CN=2)=C1 JMQUFKAINVANSW-UHFFFAOYSA-N 0.000 description 1
- GLCKZUYTFKFAMK-UHFFFAOYSA-N 5-[[2-(3,5-dimethoxy-4-methylanilino)-5-fluoropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 GLCKZUYTFKFAMK-UHFFFAOYSA-N 0.000 description 1
- JVBYWYIIGLWBAS-UHFFFAOYSA-N 5-[[2-(3-amino-4-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(N)C(OC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 JVBYWYIIGLWBAS-UHFFFAOYSA-N 0.000 description 1
- NTGRYWTYJPJSFJ-UHFFFAOYSA-N 5-[[2-(3-chloro-4,5-dimethoxyanilino)-5-fluoropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.ClC1=C(OC)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 NTGRYWTYJPJSFJ-UHFFFAOYSA-N 0.000 description 1
- QHDWBLMOMGHAKK-UHFFFAOYSA-N 5-[[2-(3-ethenylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=CC(C=C)=C1 QHDWBLMOMGHAKK-UHFFFAOYSA-N 0.000 description 1
- JJYGXMMABJKTPH-UHFFFAOYSA-N 5-[[2-(3-ethoxy-4,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CC1=C(C)C(OCC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 JJYGXMMABJKTPH-UHFFFAOYSA-N 0.000 description 1
- KUVHOKHWQZUWKO-UHFFFAOYSA-N 5-[[2-(3-fluoro-5-methoxy-4-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 KUVHOKHWQZUWKO-UHFFFAOYSA-N 0.000 description 1
- AVKXPBUFMRDXEH-UHFFFAOYSA-N 5-[[2-(3-hydroxy-4,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 AVKXPBUFMRDXEH-UHFFFAOYSA-N 0.000 description 1
- HBOCQIHDTUDVTP-UHFFFAOYSA-N 5-[[2-(3-methoxy-4,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3-methyl-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4N(C)C(=O)OC4=CC=3)C(C)=CN=2)=C1 HBOCQIHDTUDVTP-UHFFFAOYSA-N 0.000 description 1
- UNKOKUNFRCIYFW-UHFFFAOYSA-N 5-[[2-(3-methoxy-4,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 UNKOKUNFRCIYFW-UHFFFAOYSA-N 0.000 description 1
- GJVDQCKJPLJQMN-UHFFFAOYSA-N 5-[[2-(3-methoxy-4,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(C)=CN=2)=C1 GJVDQCKJPLJQMN-UHFFFAOYSA-N 0.000 description 1
- COTIWYLHNXISES-UHFFFAOYSA-N 5-[[2-(3-methoxy-4-methylanilino)-5-nitropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(=CN=2)[N+]([O-])=O)=C1 COTIWYLHNXISES-UHFFFAOYSA-N 0.000 description 1
- QCOQSJQNULAJKM-UHFFFAOYSA-N 5-[[2-(4-bromo-2-fluoro-3-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=C(Br)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1F QCOQSJQNULAJKM-UHFFFAOYSA-N 0.000 description 1
- HRWLPOMEBUHZLR-UHFFFAOYSA-N 5-[[2-(4-bromo-2-fluoroanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(Br)C=C1F HRWLPOMEBUHZLR-UHFFFAOYSA-N 0.000 description 1
- UMDISBJYUCBPFF-UHFFFAOYSA-N 5-[[2-(4-chloro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(Cl)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 UMDISBJYUCBPFF-UHFFFAOYSA-N 0.000 description 1
- ZWTTWPXVYXPGTD-UHFFFAOYSA-N 5-[[2-(4-ethyl-2-fluoro-3-methoxyanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=C(OC)C(CC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ZWTTWPXVYXPGTD-UHFFFAOYSA-N 0.000 description 1
- VROLPBWAQGBYKK-UHFFFAOYSA-N 5-[[2-(4-fluoro-3,5-dimethylanilino)-5-(hydroxymethyl)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(F)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(CO)=CN=2)=C1 VROLPBWAQGBYKK-UHFFFAOYSA-N 0.000 description 1
- GZCZJWRMRAOXIT-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-hydroxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC(C)=C(F)C(O)=C1 GZCZJWRMRAOXIT-UHFFFAOYSA-N 0.000 description 1
- OYFMQDVLFYKOPZ-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 OYFMQDVLFYKOPZ-UHFFFAOYSA-N 0.000 description 1
- JAEWYAMEKSUVPM-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;methanesulfonic acid Chemical compound CS(O)(=O)=O.CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 JAEWYAMEKSUVPM-UHFFFAOYSA-N 0.000 description 1
- FPXZBGCWCQPXEV-UHFFFAOYSA-N 5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;sulfuric acid Chemical compound OS(O)(=O)=O.CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 FPXZBGCWCQPXEV-UHFFFAOYSA-N 0.000 description 1
- GGKVSHKBQILWRO-UHFFFAOYSA-N 5-[[2-(4-tert-butylanilino)-5-fluoropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(C(C)(C)C)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 GGKVSHKBQILWRO-UHFFFAOYSA-N 0.000 description 1
- IYJHSBLERTUKDP-UHFFFAOYSA-N 5-[[2-(naphthalen-2-ylamino)-5-nitropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C=CC=CC4=CC=3)=NC=C2[N+](=O)[O-])=C1 IYJHSBLERTUKDP-UHFFFAOYSA-N 0.000 description 1
- YHAJJEDRVIJGAL-UHFFFAOYSA-N 5-[[2-[(2,6-dimethylpyridin-4-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=NC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 YHAJJEDRVIJGAL-UHFFFAOYSA-N 0.000 description 1
- NNKSULDBUXEEOO-UHFFFAOYSA-N 5-[[2-[(2-methoxypyridin-4-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=NC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 NNKSULDBUXEEOO-UHFFFAOYSA-N 0.000 description 1
- CUNSROAQMVAZLV-UHFFFAOYSA-N 5-[[2-[(4,5-dimethylpyridin-2-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(C)=CN=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 CUNSROAQMVAZLV-UHFFFAOYSA-N 0.000 description 1
- HQEVGGDLAHPTAK-UHFFFAOYSA-N 5-[[2-[(4,6-dimethylpyridin-2-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC(C)=NC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 HQEVGGDLAHPTAK-UHFFFAOYSA-N 0.000 description 1
- OFIZYDOJWBJMHX-UHFFFAOYSA-N 5-[[2-[(5,6-dimethylpyridin-2-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(C)C(C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 OFIZYDOJWBJMHX-UHFFFAOYSA-N 0.000 description 1
- IWWZUOFIDGTQMD-UHFFFAOYSA-N 5-[[2-[(6-methoxypyridin-2-yl)amino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=N1 IWWZUOFIDGTQMD-UHFFFAOYSA-N 0.000 description 1
- CFSBKLWTWMHTBC-UHFFFAOYSA-N 5-[[2-[2-fluoro-3,4-bis(2-methoxyethoxy)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=C(OCCOC)C(OCCOC)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 CFSBKLWTWMHTBC-UHFFFAOYSA-N 0.000 description 1
- KDJCOZKHECFPBB-UHFFFAOYSA-N 5-[[2-[2-fluoro-3-(2-methoxyethoxy)-4-methylanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COCCOC1=C(C)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1F KDJCOZKHECFPBB-UHFFFAOYSA-N 0.000 description 1
- QYYITZDBQZKOLN-UHFFFAOYSA-N 5-[[2-[2-fluoro-3-(2-methoxyethoxy)-4-methylanilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COCCOC1=C(C)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C=CN=2)=C1F QYYITZDBQZKOLN-UHFFFAOYSA-N 0.000 description 1
- VFKZJNPGIPLQCI-UHFFFAOYSA-N 5-[[2-[3-(difluoromethyl)-4-methoxyanilino]-5-fluoropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.C1=C(C(F)F)C(OC)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 VFKZJNPGIPLQCI-UHFFFAOYSA-N 0.000 description 1
- NWODTCNZENWTOY-UHFFFAOYSA-N 5-[[2-[3-(difluoromethyl)-5-methoxyanilino]-5-fluoropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC(F)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 NWODTCNZENWTOY-UHFFFAOYSA-N 0.000 description 1
- JEPTVSSWKRQJLD-UHFFFAOYSA-N 5-[[2-[3-(dimethylamino)-4,5-dimethylanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(N(C)C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 JEPTVSSWKRQJLD-UHFFFAOYSA-N 0.000 description 1
- YNKCDAARVJNKSA-UHFFFAOYSA-N 5-[[2-[3-(dimethylamino)-4-methylanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(N(C)C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 YNKCDAARVJNKSA-UHFFFAOYSA-N 0.000 description 1
- YVRYSNGXLGNLFO-UHFFFAOYSA-N 5-[[2-[3-(dimethylamino)-4-methylanilino]-5-nitropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C)C(N(C)C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(=CN=2)[N+]([O-])=O)=C1 YVRYSNGXLGNLFO-UHFFFAOYSA-N 0.000 description 1
- YSQNLYBWTIBHFU-UHFFFAOYSA-N 5-[[2-[3-(dimethylamino)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CN(C)C1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 YSQNLYBWTIBHFU-UHFFFAOYSA-N 0.000 description 1
- LPJSGIBWNPXPJX-UHFFFAOYSA-N 5-[[2-[3-(ethylamino)-4,5-dimethylanilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.CC1=C(C)C(NCC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 LPJSGIBWNPXPJX-UHFFFAOYSA-N 0.000 description 1
- YUQIJGOQCPKEIM-UHFFFAOYSA-N 5-[[2-[3-methoxy-5-(trifluoromethyl)anilino]-5-nitropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC(F)(F)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(=CN=2)[N+]([O-])=O)=C1 YUQIJGOQCPKEIM-UHFFFAOYSA-N 0.000 description 1
- COUPJNGWDHLZGN-UHFFFAOYSA-N 5-[[2-[4-(aminomethyl)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=C(CN)C=C1 COUPJNGWDHLZGN-UHFFFAOYSA-N 0.000 description 1
- ZOLLHYPYOQXTEW-UHFFFAOYSA-N 5-[[2-[4-(dimethylamino)anilino]-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=CC(N(C)C)=CC=C1NC1=NC=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ZOLLHYPYOQXTEW-UHFFFAOYSA-N 0.000 description 1
- BEEQJJFPNMIRDP-UHFFFAOYSA-N 5-[[2-[4-[1-(cyclopropylamino)ethyl]anilino]-5-fluoropyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.C=1C=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)C=CC=1C(C)NC1CC1 BEEQJJFPNMIRDP-UHFFFAOYSA-N 0.000 description 1
- GMZVMSJYNZWIPD-UHFFFAOYSA-N 5-[[5-(diethylaminomethyl)-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(CN(CC)CC)=CN=C1NC1=CC(C)=C(C)C(C)=C1 GMZVMSJYNZWIPD-UHFFFAOYSA-N 0.000 description 1
- AAMICGWLGOWTGQ-UHFFFAOYSA-N 5-[[5-(hydroxymethyl)-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(CO)=CN=2)=C1 AAMICGWLGOWTGQ-UHFFFAOYSA-N 0.000 description 1
- ZCBLRDRYHMWLTJ-UHFFFAOYSA-N 5-[[5-(hydroxymethyl)-2-(3-methoxy-4,5-dimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(CO)=CN=2)=C1 ZCBLRDRYHMWLTJ-UHFFFAOYSA-N 0.000 description 1
- PTWFXANMNNESDZ-UHFFFAOYSA-N 5-[[5-(piperidin-1-ylmethyl)-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(CN3CCCCC3)=CN=2)=C1 PTWFXANMNNESDZ-UHFFFAOYSA-N 0.000 description 1
- KPJOYTSBHHLWFP-UHFFFAOYSA-N 5-[[5-(pyrrolidin-1-ylmethyl)-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(CN3CCCC3)=CN=2)=C1 KPJOYTSBHHLWFP-UHFFFAOYSA-N 0.000 description 1
- BZGCHAYSFFSKTK-UHFFFAOYSA-N 5-[[5-bromo-2-(2-fluoro-3-methoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Br)=CN=2)=C1F BZGCHAYSFFSKTK-UHFFFAOYSA-N 0.000 description 1
- BEEMSVKKXCONKT-UHFFFAOYSA-N 5-[[5-bromo-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Br)=CN=2)=C1 BEEMSVKKXCONKT-UHFFFAOYSA-N 0.000 description 1
- DUZMXPNXGJGDQS-UHFFFAOYSA-N 5-[[5-chloro-2-(2,4-difluoro-3-methoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=C(F)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1F DUZMXPNXGJGDQS-UHFFFAOYSA-N 0.000 description 1
- RMFRBTUIRARYSZ-UHFFFAOYSA-N 5-[[5-chloro-2-(2-fluoro-3,4-dimethoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=C(OC)C(OC)=CC=C1NC1=NC=C(Cl)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 RMFRBTUIRARYSZ-UHFFFAOYSA-N 0.000 description 1
- ROPTYKBVEBINSV-UHFFFAOYSA-N 5-[[5-chloro-2-(2-fluoro-3-methoxy-4-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=C(C)C=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1F ROPTYKBVEBINSV-UHFFFAOYSA-N 0.000 description 1
- VJCCPKSVAOLCRI-UHFFFAOYSA-N 5-[[5-chloro-2-(2-fluoro-3-methoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1F VJCCPKSVAOLCRI-UHFFFAOYSA-N 0.000 description 1
- VLECTBJEUXXLQO-UHFFFAOYSA-N 5-[[5-chloro-2-(2-fluoro-4-methoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=CC(OC)=CC=C1NC1=NC=C(Cl)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 VLECTBJEUXXLQO-UHFFFAOYSA-N 0.000 description 1
- GENIXLCRLWAHAZ-UHFFFAOYSA-N 5-[[5-chloro-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 GENIXLCRLWAHAZ-UHFFFAOYSA-N 0.000 description 1
- BNVYMOWVFHEBJR-UHFFFAOYSA-N 5-[[5-chloro-2-(3,4-dimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C)C(C)=CC=C1NC1=NC=C(Cl)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 BNVYMOWVFHEBJR-UHFFFAOYSA-N 0.000 description 1
- XELNVNDCHYKDEC-UHFFFAOYSA-N 5-[[5-chloro-2-(3,5-difluoroanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=CC(F)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 XELNVNDCHYKDEC-UHFFFAOYSA-N 0.000 description 1
- KEMDDOAWMAXOOG-UHFFFAOYSA-N 5-[[5-chloro-2-(3,5-dimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 KEMDDOAWMAXOOG-UHFFFAOYSA-N 0.000 description 1
- ZFYSYKRCYOUDGE-UHFFFAOYSA-N 5-[[5-chloro-2-(3-chloro-5-fluoroanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.FC1=CC(Cl)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 ZFYSYKRCYOUDGE-UHFFFAOYSA-N 0.000 description 1
- MBFYWTCTJXNXMA-UHFFFAOYSA-N 5-[[5-chloro-2-(3-ethoxy-4,5-dimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CC1=C(C)C(OCC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 MBFYWTCTJXNXMA-UHFFFAOYSA-N 0.000 description 1
- HJDNERITBHSIQC-UHFFFAOYSA-N 5-[[5-chloro-2-(3-methoxy-4,5-dimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 HJDNERITBHSIQC-UHFFFAOYSA-N 0.000 description 1
- YHZZPEATIMDJTN-UHFFFAOYSA-N 5-[[5-chloro-2-(3-methoxy-4-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 YHZZPEATIMDJTN-UHFFFAOYSA-N 0.000 description 1
- ORBXGUMDIAQKRZ-UHFFFAOYSA-N 5-[[5-chloro-2-(4-ethyl-2-fluoro-3-methoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=C(OC)C(CC)=CC=C1NC1=NC=C(Cl)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ORBXGUMDIAQKRZ-UHFFFAOYSA-N 0.000 description 1
- VPPRBIQUABUKSB-UHFFFAOYSA-N 5-[[5-chloro-2-[2-fluoro-3,4-bis(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=C(OCCOC)C(OCCOC)=CC=C1NC1=NC=C(Cl)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 VPPRBIQUABUKSB-UHFFFAOYSA-N 0.000 description 1
- AEQXTASGRDDEQY-UHFFFAOYSA-N 5-[[5-chloro-2-[3-(diethylamino)-4,5-dimethylanilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.CC1=C(C)C(N(CC)CC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 AEQXTASGRDDEQY-UHFFFAOYSA-N 0.000 description 1
- POLNHIPOHBFNGV-UHFFFAOYSA-N 5-[[5-chloro-2-[3-(dimethylamino)-4,5-dimethylanilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(N(C)C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 POLNHIPOHBFNGV-UHFFFAOYSA-N 0.000 description 1
- HXYFJBBTYSXNHN-UHFFFAOYSA-N 5-[[5-chloro-2-[3-(dimethylamino)-4-methylanilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C)C(N(C)C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 HXYFJBBTYSXNHN-UHFFFAOYSA-N 0.000 description 1
- UMLVVHPQYZPUOP-UHFFFAOYSA-N 5-[[5-chloro-2-[3-(ethylamino)-4,5-dimethylanilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.CC1=C(C)C(NCC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 UMLVVHPQYZPUOP-UHFFFAOYSA-N 0.000 description 1
- MYLQPUBECGCDRQ-UHFFFAOYSA-N 5-[[5-chloro-2-[3-methoxy-5-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound FC(F)(F)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(Cl)=CN=2)=C1 MYLQPUBECGCDRQ-UHFFFAOYSA-N 0.000 description 1
- ATYYPGKXUVOHPQ-UHFFFAOYSA-N 5-[[5-chloro-2-[4-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(C(F)(F)F)=CC=C1NC1=NC=C(Cl)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 ATYYPGKXUVOHPQ-UHFFFAOYSA-N 0.000 description 1
- BMMXMRZEGJNSHN-UHFFFAOYSA-N 5-[[5-chloro-2-[4-methyl-3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C(C(F)(F)F)C(C)=CC=C1NC1=NC=C(Cl)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 BMMXMRZEGJNSHN-UHFFFAOYSA-N 0.000 description 1
- XIKRLGAXJHDMTA-UHFFFAOYSA-N 5-[[5-ethynyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C#C)=CN=2)=C1 XIKRLGAXJHDMTA-UHFFFAOYSA-N 0.000 description 1
- QYXDPMBTIORZRQ-UHFFFAOYSA-N 5-[[5-fluoro-2-(2-fluoro-3-methoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=CC=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1F QYXDPMBTIORZRQ-UHFFFAOYSA-N 0.000 description 1
- MEDJFAMZPLGSJI-UHFFFAOYSA-N 5-[[5-fluoro-2-(2-fluoro-5-methoxy-4-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1F MEDJFAMZPLGSJI-UHFFFAOYSA-N 0.000 description 1
- JHQZBABCLVFFOB-UHFFFAOYSA-N 5-[[5-fluoro-2-(2-fluoro-5-methoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound COC1=CC=C(F)C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 JHQZBABCLVFFOB-UHFFFAOYSA-N 0.000 description 1
- PEXMFLWVCUGKCK-UHFFFAOYSA-N 5-[[5-fluoro-2-(3-fluoro-5-methoxy-4-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.FC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 PEXMFLWVCUGKCK-UHFFFAOYSA-N 0.000 description 1
- DXUIJJIHRUCPGC-UHFFFAOYSA-N 5-[[5-fluoro-2-(3-fluoro-5-morpholin-4-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.C=1C(F)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=CC=1N1CCOCC1 DXUIJJIHRUCPGC-UHFFFAOYSA-N 0.000 description 1
- ZAZJNSZVNNDZJS-UHFFFAOYSA-N 5-[[5-fluoro-2-(3-methoxy-4,5-dimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 ZAZJNSZVNNDZJS-UHFFFAOYSA-N 0.000 description 1
- KHZDBVDMSAMEMZ-UHFFFAOYSA-N 5-[[5-fluoro-2-(3-methoxy-4,5-dimethylanilino)pyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(F)=CN=2)=C1 KHZDBVDMSAMEMZ-UHFFFAOYSA-N 0.000 description 1
- TWHUNGUPDQPYLV-UHFFFAOYSA-N 5-[[5-fluoro-2-(3-methoxy-4-pyridin-4-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.COC1=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=CC=C1C1=CC=NC=C1 TWHUNGUPDQPYLV-UHFFFAOYSA-N 0.000 description 1
- UCWSGAMXMRLDEX-UHFFFAOYSA-N 5-[[5-fluoro-2-(3-methoxy-5-methylanilino)pyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(F)=CN=2)=C1 UCWSGAMXMRLDEX-UHFFFAOYSA-N 0.000 description 1
- NWQVDRDUGDSIMW-UHFFFAOYSA-N 5-[[5-fluoro-2-(3-methylsulfonylanilino)pyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C=1C=2NC(=O)OC=2C(C)=CC=1NC(C(=CN=1)F)=NC=1NC1=CC=CC(S(C)(=O)=O)=C1 NWQVDRDUGDSIMW-UHFFFAOYSA-N 0.000 description 1
- GNDHRBINUQZCFN-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-fluoro-3-methoxy-5-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 GNDHRBINUQZCFN-UHFFFAOYSA-N 0.000 description 1
- RYFZBRREBQSYRQ-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-fluoro-3-methylsulfonylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(F)C(S(=O)(=O)C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 RYFZBRREBQSYRQ-UHFFFAOYSA-N 0.000 description 1
- ITDOYGYMEWVKTK-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-fluoro-3-methylsulfonylanilino)pyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one Chemical compound C=1C=2NC(=O)OC=2C(C)=CC=1NC(C(=CN=1)F)=NC=1NC1=CC=C(F)C(S(C)(=O)=O)=C1 ITDOYGYMEWVKTK-UHFFFAOYSA-N 0.000 description 1
- PJSFYGWRDRCBIJ-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-fluoro-3-pyridin-3-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(F)=CN=C1NC(C=1)=CC=C(F)C=1C1=CC=CN=C1 PJSFYGWRDRCBIJ-UHFFFAOYSA-N 0.000 description 1
- CZTRBCDKVZGMAM-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-fluoro-3-pyridin-4-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(F)=CN=C1NC(C=1)=CC=C(F)C=1C1=CC=NC=C1 CZTRBCDKVZGMAM-UHFFFAOYSA-N 0.000 description 1
- CAEAKBSFASJTNI-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-methoxy-3-methylanilino)pyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C)C(OC)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=C(C)C=2)=N1 CAEAKBSFASJTNI-UHFFFAOYSA-N 0.000 description 1
- XWRRTJFJLBCAMT-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-methoxy-3-pyridin-4-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.COC1=CC=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)C=C1C1=CC=NC=C1 XWRRTJFJLBCAMT-UHFFFAOYSA-N 0.000 description 1
- HYSCOLCJYCPNSG-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-methoxyanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;formic acid Chemical compound OC=O.C1=CC(OC)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 HYSCOLCJYCPNSG-UHFFFAOYSA-N 0.000 description 1
- KWKQAHGTZVWORD-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-methyl-3-methylsulfonylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(S(C)(=O)=O)C(C)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 KWKQAHGTZVWORD-UHFFFAOYSA-N 0.000 description 1
- VBVDSBUIMQLWLW-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-methyl-3-pyridin-3-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)C=C1C1=CC=CN=C1 VBVDSBUIMQLWLW-UHFFFAOYSA-N 0.000 description 1
- ZGCZJVPJRQRDNE-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-methyl-3-pyridin-4-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=CC=C(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)C=C1C1=CC=NC=C1 ZGCZJVPJRQRDNE-UHFFFAOYSA-N 0.000 description 1
- KIYPEMMSKNWKEE-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(C)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 KIYPEMMSKNWKEE-UHFFFAOYSA-N 0.000 description 1
- SQIMBNBBTOWRQC-UHFFFAOYSA-N 5-[[5-fluoro-2-(4-propan-2-ylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=CC(C(C)C)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 SQIMBNBBTOWRQC-UHFFFAOYSA-N 0.000 description 1
- KUCUJYUEAZVWMJ-UHFFFAOYSA-N 5-[[5-fluoro-2-[(1-methyl-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2CCCC(=O)N(C)C2=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 KUCUJYUEAZVWMJ-UHFFFAOYSA-N 0.000 description 1
- WYYLUCMSXUQMEC-UHFFFAOYSA-N 5-[[5-fluoro-2-[(2-morpholin-4-ylpyridin-4-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(F)=CN=C1NC(C=1)=CC=NC=1N1CCOCC1 WYYLUCMSXUQMEC-UHFFFAOYSA-N 0.000 description 1
- HUVQIFXDUJBESK-UHFFFAOYSA-N 5-[[5-fluoro-2-[(2-oxo-3,4-dihydro-1h-quinolin-6-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4CCC(=O)NC4=CC=3)=NC=C2F)=C1 HUVQIFXDUJBESK-UHFFFAOYSA-N 0.000 description 1
- UDBVOVPVELQKBE-UHFFFAOYSA-N 5-[[5-fluoro-2-[(7-oxo-5,6,8,9-tetrahydrobenzo[7]annulen-3-yl)amino]pyrimidin-4-yl]amino]-3H-1,3-benzoxazol-2-one formic acid Chemical compound OC=O.OC=O.Fc1cnc(Nc2ccc3CCC(=O)CCc3c2)nc1Nc1ccc2oc(=O)[nH]c2c1 UDBVOVPVELQKBE-UHFFFAOYSA-N 0.000 description 1
- OSQOUTSCKJPZMB-UHFFFAOYSA-N 5-[[5-fluoro-2-[(7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl)amino]pyrimidin-4-yl]amino]-3H-1,3-benzoxazol-2-one formic acid Chemical compound OC=O.OC=O.Fc1cnc(Nc2ccc3CCC(CCc3c2)N2CCCC2)nc1Nc1ccc2oc(=O)[nH]c2c1 OSQOUTSCKJPZMB-UHFFFAOYSA-N 0.000 description 1
- WIZRBYQINNOORW-UHFFFAOYSA-N 5-[[5-fluoro-2-[3-(fluoromethyl)-5-methoxyanilino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=CC(CF)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(F)=CN=2)=C1 WIZRBYQINNOORW-UHFFFAOYSA-N 0.000 description 1
- KZYVIYYNJZQSKZ-UHFFFAOYSA-N 5-[[5-fluoro-2-[3-methoxy-5-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]-7-methyl-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical class OC(=O)C(F)(F)F.FC(F)(F)C1=CC(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(C)C=3)C(F)=CN=2)=C1 KZYVIYYNJZQSKZ-UHFFFAOYSA-N 0.000 description 1
- JZHBAFFHUGUDLQ-UHFFFAOYSA-N 5-[[5-fluoro-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidin-2-yl]amino]-2-methylbenzonitrile;formic acid Chemical compound OC=O.C1=C(C#N)C(C)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=CC=2)=N1 JZHBAFFHUGUDLQ-UHFFFAOYSA-N 0.000 description 1
- ABOOBVBGPKLURH-UHFFFAOYSA-N 5-[[5-methyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-7-(piperazin-1-ylmethyl)-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(CN4CCNCC4)C=3)C(C)=CN=2)=C1 ABOOBVBGPKLURH-UHFFFAOYSA-N 0.000 description 1
- MYJJPCQFOUOANK-UHFFFAOYSA-N 5-[[5-methyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-7-(piperidin-1-ylmethyl)-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(CN4CCCCC4)C=3)C(C)=CN=2)=C1 MYJJPCQFOUOANK-UHFFFAOYSA-N 0.000 description 1
- ZKRUHYBDTRDFJI-UHFFFAOYSA-N 5-[[5-methyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-7-(pyrrolidin-1-ylmethyl)-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(CN4CCCC4)C=3)C(C)=CN=2)=C1 ZKRUHYBDTRDFJI-UHFFFAOYSA-N 0.000 description 1
- YOOHQYJTDNEQLP-UHFFFAOYSA-N 5-[[5-methyl-2-(n-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N=1C=C(C)C(NC=2C=C3NC(=O)OC3=CC=2)=NC=1N(C)C1=CC=CC=C1 YOOHQYJTDNEQLP-UHFFFAOYSA-N 0.000 description 1
- IDZMUHBYLFPLNP-UHFFFAOYSA-N 5-[[5-methyl-2-(pyridin-4-ylamino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC1=CC=NC=C1 IDZMUHBYLFPLNP-UHFFFAOYSA-N 0.000 description 1
- HVXFMODEEXXGSR-UHFFFAOYSA-N 5-[[5-methyl-2-[(1-oxo-3h-2-benzofuran-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4COC(=O)C4=CC=3)=NC=C2C)=C1 HVXFMODEEXXGSR-UHFFFAOYSA-N 0.000 description 1
- WXFBOTKOUSHWKH-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-methylpyridin-4-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=NC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(C)=CN=2)=C1 WXFBOTKOUSHWKH-UHFFFAOYSA-N 0.000 description 1
- CXSOZHABESXHQP-UHFFFAOYSA-N 5-[[5-methyl-2-[(2-morpholin-4-ylpyridin-4-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C)=CN=C1NC(C=1)=CC=NC=1N1CCOCC1 CXSOZHABESXHQP-UHFFFAOYSA-N 0.000 description 1
- HOSGMIPJIISPNQ-UHFFFAOYSA-N 5-[[5-methyl-2-[(3-oxo-1,2-dihydroisoindol-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C(=O)NCC4=CC=3)=NC=C2C)=C1 HOSGMIPJIISPNQ-UHFFFAOYSA-N 0.000 description 1
- YYWLPIYQOFDPTB-UHFFFAOYSA-N 5-[[5-methyl-2-[(3-oxo-1h-2-benzofuran-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C(=O)OCC4=CC=3)=NC=C2C)=C1 YYWLPIYQOFDPTB-UHFFFAOYSA-N 0.000 description 1
- DYFCHMMPQXMIMI-UHFFFAOYSA-N 5-[[5-methyl-2-[(7-methyl-1-oxo-3h-2-benzofuran-4-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC2=CC=C(C=3C(=O)OCC=32)C)=C1 DYFCHMMPQXMIMI-UHFFFAOYSA-N 0.000 description 1
- YZJYFHDRGFODCL-UHFFFAOYSA-N 5-[[5-methyl-2-[(7-methyl-3-oxo-1h-2-benzofuran-5-yl)amino]pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1=C2OC(=O)NC2=CC(NC=2C(C)=CN=C(N=2)NC=2C=C(C=3COC(=O)C=3C=2)C)=C1 YZJYFHDRGFODCL-UHFFFAOYSA-N 0.000 description 1
- LBQMQLOLUKUONZ-UHFFFAOYSA-N 5-[[5-nitro-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=CC=3)C(=CN=2)[N+]([O-])=O)=C1 LBQMQLOLUKUONZ-UHFFFAOYSA-N 0.000 description 1
- GMMWNTHAIOJBSD-UHFFFAOYSA-N 6-chloro-4-n-(2,3-dimethylphenyl)-2-n,2-n-dimethylpyrimidine-2,4-diamine Chemical compound CN(C)C1=NC(Cl)=CC(NC=2C(=C(C)C=CC=2)C)=N1 GMMWNTHAIOJBSD-UHFFFAOYSA-N 0.000 description 1
- AZLVYVSJYZVZMF-UHFFFAOYSA-N 7-(1,3-benzodioxol-5-yl)-5-[[5-methyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound N1=C(NC=2C=C3NC(=O)OC3=C(C=3C=C4OCOC4=CC=3)C=2)C(C)=CN=C1NC1=CC(C)=C(C)C(C)=C1 AZLVYVSJYZVZMF-UHFFFAOYSA-N 0.000 description 1
- MHADEGJBEHVPLK-UHFFFAOYSA-N 7-[(4-methylpiperazin-1-yl)methyl]-5-[[5-methyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound C1CN(C)CCN1CC1=CC(NC=2C(=CN=C(NC=3C=C(C)C(C)=C(C)C=3)N=2)C)=CC2=C1OC(=O)N2 MHADEGJBEHVPLK-UHFFFAOYSA-N 0.000 description 1
- ZSJZPVKDVHLLMY-AATRIKPKSA-N 7-[(e)-3-chloroprop-1-enyl]-5-[[5-methyl-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(\C=C\CCl)C=3)C(C)=CN=2)=C1 ZSJZPVKDVHLLMY-AATRIKPKSA-N 0.000 description 1
- MYJXEUCTSLFVMT-UHFFFAOYSA-N 7-fluoro-5-[[2-(3-methoxy-4,5-dimethylanilino)-5-methylpyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(C)=CN=2)=C1 MYJXEUCTSLFVMT-UHFFFAOYSA-N 0.000 description 1
- FJZFFJAKWGAWTA-UHFFFAOYSA-N 7-fluoro-5-[[5-fluoro-2-(3,4,5-trimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(C)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(F)=CN=2)=C1 FJZFFJAKWGAWTA-UHFFFAOYSA-N 0.000 description 1
- KDRIHHPGUSJURX-UHFFFAOYSA-N 7-fluoro-5-[[5-fluoro-2-(3-methoxy-4,5-dimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(C)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(F)=CN=2)=C1 KDRIHHPGUSJURX-UHFFFAOYSA-N 0.000 description 1
- WEWCWKAJOYGRDO-UHFFFAOYSA-N 7-fluoro-5-[[5-fluoro-2-(3-methoxy-5-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.COC1=CC(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(F)=CN=2)=C1 WEWCWKAJOYGRDO-UHFFFAOYSA-N 0.000 description 1
- KMOXAHUISBYYTL-UHFFFAOYSA-N 7-fluoro-5-[[5-fluoro-2-(4-fluoro-3,5-dimethylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one Chemical compound CC1=C(F)C(C)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(F)=CN=2)=C1 KMOXAHUISBYYTL-UHFFFAOYSA-N 0.000 description 1
- IGPSEQFSCWPGTM-UHFFFAOYSA-N 7-fluoro-5-[[5-fluoro-2-(4-fluoro-3-methoxy-5-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CC1=C(F)C(OC)=CC(NC=2N=C(NC=3C=C4NC(=O)OC4=C(F)C=3)C(F)=CN=2)=C1 IGPSEQFSCWPGTM-UHFFFAOYSA-N 0.000 description 1
- OMUNJMWWNCOIJV-UHFFFAOYSA-N 7-fluoro-5-[[5-fluoro-2-(4-methoxy-3-methylanilino)pyrimidin-4-yl]amino]-3h-1,3-benzoxazol-2-one;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C(C)C(OC)=CC=C1NC1=NC=C(F)C(NC=2C=C3NC(=O)OC3=C(F)C=2)=N1 OMUNJMWWNCOIJV-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- DIXRAPLTRJVGQO-UHFFFAOYSA-N C(=O)O.C(C1=CC=CC=C1)(=O)NC(F)(F)F Chemical compound C(=O)O.C(C1=CC=CC=C1)(=O)NC(F)(F)F DIXRAPLTRJVGQO-UHFFFAOYSA-N 0.000 description 1
- GVCYQWGKBLGFDL-UHFFFAOYSA-N CCCN(C(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC4=C(C=C3)OC(=O)N4)F)C(=O)O Chemical compound CCCN(C(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NC3=CC4=C(C=C3)OC(=O)N4)F)C(=O)O GVCYQWGKBLGFDL-UHFFFAOYSA-N 0.000 description 1
- VOZCAZVEYAISJM-UHFFFAOYSA-N COC1=C(C=CC(=C1)NC2=NC=C(C(=N2)NC3=CC4=C(C=C3)OC(=O)N4)F)C(=O)N(C5CCC5)C(=O)O Chemical compound COC1=C(C=CC(=C1)NC2=NC=C(C(=N2)NC3=CC4=C(C=C3)OC(=O)N4)F)C(=O)N(C5CCC5)C(=O)O VOZCAZVEYAISJM-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- GGSOJIIUBDMBTR-UHFFFAOYSA-N FC(C(=O)O)(F)F.N1C(CC=CC=C1)=O Chemical compound FC(C(=O)O)(F)F.N1C(CC=CC=C1)=O GGSOJIIUBDMBTR-UHFFFAOYSA-N 0.000 description 1
- HBOLEJXIOHWYIF-UHFFFAOYSA-M FC1=C(C=C(C=C1C)NC1=NC=C(C(=N1)NC=1C=CC2=C(N(C(O2)=O)[Ca]C)C1)C)OC.P(=O)(O)(O)O Chemical compound FC1=C(C=C(C=C1C)NC1=NC=C(C(=N1)NC=1C=CC2=C(N(C(O2)=O)[Ca]C)C1)C)OC.P(=O)(O)(O)O HBOLEJXIOHWYIF-UHFFFAOYSA-M 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 102000000551 Syk Kinase Human genes 0.000 description 1
- 108010016672 Syk Kinase Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 208000002205 allergic conjunctivitis Diseases 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 125000005228 aryl sulfonate group Chemical group 0.000 description 1
- 208000024998 atopic conjunctivitis Diseases 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- ZRHCRAIVTOEDTD-UHFFFAOYSA-N methyl 2-(2,4-difluoro-3-methoxyanilino)-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidine-5-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C(=O)OC)=CN=C1NC1=CC=C(F)C(OC)=C1F ZRHCRAIVTOEDTD-UHFFFAOYSA-N 0.000 description 1
- YDDSESZOKYMUKP-UHFFFAOYSA-N methyl 2-(3-methoxy-4,5-dimethylanilino)-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidine-5-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C(=O)OC)=CN=C1NC1=CC(C)=C(C)C(OC)=C1 YDDSESZOKYMUKP-UHFFFAOYSA-N 0.000 description 1
- KIAXIAMBFXCNAN-UHFFFAOYSA-N methyl 2-(3-methoxy-4-methylanilino)-4-[(2-oxo-3H-1,3-benzoxazol-5-yl)amino]pyrimidine-5-carboxylate Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C(=O)OC)=CN=C1NC1=CC=C(C)C(OC)=C1 KIAXIAMBFXCNAN-UHFFFAOYSA-N 0.000 description 1
- IMJZNRBKRFCBTC-UHFFFAOYSA-N methyl 2-(4-carbamoylanilino)-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidine-5-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C(=O)OC)=CN=C1NC1=CC=C(C(N)=O)C=C1 IMJZNRBKRFCBTC-UHFFFAOYSA-N 0.000 description 1
- OHCPSBQCCLBHGV-UHFFFAOYSA-N methyl 2-(4-fluoro-3-methoxy-5-methylanilino)-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidine-5-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C(=O)OC)=CN=C1NC1=CC(C)=C(F)C(OC)=C1 OHCPSBQCCLBHGV-UHFFFAOYSA-N 0.000 description 1
- JUZIQDBQDKQUMH-UHFFFAOYSA-N methyl 2-(naphthalen-2-ylamino)-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidine-5-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.C1=C2OC(=O)NC2=CC(NC2=NC(NC=3C=C4C=CC=CC4=CC=3)=NC=C2C(=O)OC)=C1 JUZIQDBQDKQUMH-UHFFFAOYSA-N 0.000 description 1
- BTBFLTHSGSQXNF-UHFFFAOYSA-N methyl 2-[3-(dimethylamino)-4-methylanilino]-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidine-5-carboxylate;2,2,2-trifluoroacetic acid Chemical class OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C(=O)OC)=CN=C1NC1=CC=C(C)C(N(C)C)=C1 BTBFLTHSGSQXNF-UHFFFAOYSA-N 0.000 description 1
- KJXXLUHGCDCROD-UHFFFAOYSA-N methyl 2-[3-methoxy-5-(trifluoromethyl)anilino]-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidine-5-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C(=O)OC)=CN=C1NC1=CC(OC)=CC(C(F)(F)F)=C1 KJXXLUHGCDCROD-UHFFFAOYSA-N 0.000 description 1
- GLBRHNCVISMDSG-UHFFFAOYSA-N methyl 2-anilino-4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]pyrimidine-5-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C(=O)OC)=CN=C1NC1=CC=CC=C1 GLBRHNCVISMDSG-UHFFFAOYSA-N 0.000 description 1
- VQQVGAODKFILPL-UHFFFAOYSA-N methyl 4-[(2-oxo-3h-1,3-benzoxazol-5-yl)amino]-2-(3,4,5-trimethylanilino)pyrimidine-5-carboxylate Chemical compound N1=C(NC=2C=C3NC(=O)OC3=CC=2)C(C(=O)OC)=CN=C1NC1=CC(C)=C(C)C(C)=C1 VQQVGAODKFILPL-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- RLOWWWKZYUNIDI-UHFFFAOYSA-N phosphinic chloride Chemical compound ClP=O RLOWWWKZYUNIDI-UHFFFAOYSA-N 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical group [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36857010P | 2010-07-28 | 2010-07-28 | |
| US61/368,570 | 2010-07-28 | ||
| PCT/US2011/045609 WO2012015972A1 (en) | 2010-07-28 | 2011-07-27 | Compositions and methods for inhibition of the jak pathway |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016221423A Division JP2017061518A (ja) | 2010-07-28 | 2016-11-14 | Ｊａｋ経路の阻害のための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013536179A JP2013536179A (ja) | 2013-09-19 |
| JP2013536179A5 true JP2013536179A5 (enExample) | 2014-09-11 |
| JP6073221B2 JP6073221B2 (ja) | 2017-02-01 |
Family
ID=44504225
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013521954A Expired - Fee Related JP6073221B2 (ja) | 2010-07-28 | 2011-07-27 | Ｊａｋ経路の阻害のための組成物および方法 |
| JP2016221423A Withdrawn JP2017061518A (ja) | 2010-07-28 | 2016-11-14 | Ｊａｋ経路の阻害のための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016221423A Withdrawn JP2017061518A (ja) | 2010-07-28 | 2016-11-14 | Ｊａｋ経路の阻害のための組成物および方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (8) | US8343954B2 (enExample) |
| EP (1) | EP2598500B1 (enExample) |
| JP (2) | JP6073221B2 (enExample) |
| KR (1) | KR101937495B1 (enExample) |
| CN (1) | CN103201280B (enExample) |
| AR (2) | AR082408A1 (enExample) |
| AU (1) | AU2011282742B2 (enExample) |
| BR (1) | BR112013001632B1 (enExample) |
| CA (1) | CA2804199C (enExample) |
| DK (1) | DK2598500T3 (enExample) |
| EA (1) | EA201390015A1 (enExample) |
| ES (1) | ES2880622T3 (enExample) |
| IL (1) | IL223855A (enExample) |
| MX (2) | MX347331B (enExample) |
| PL (1) | PL2598500T3 (enExample) |
| PT (1) | PT2598500T (enExample) |
| RU (1) | RU2672100C2 (enExample) |
| TW (1) | TWI582090B (enExample) |
| WO (1) | WO2012015972A1 (enExample) |
| ZA (1) | ZA201300388B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070203161A1 (en) * | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
| HRP20151325T1 (hr) * | 2009-01-23 | 2016-01-01 | Rigel Pharmaceuticals, Inc. | Pripravci i postupci za inhibiciju jak puta |
| WO2012015972A1 (en) * | 2010-07-28 | 2012-02-02 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
| EP2833889B1 (en) | 2012-04-04 | 2017-11-01 | Rigel Pharmaceuticals, Inc. | Protein kinase c inhibitors and uses thereof |
| WO2013173506A2 (en) * | 2012-05-16 | 2013-11-21 | Rigel Pharmaceuticals, Inc. | Method of treating muscular degradation |
| EP2948150A1 (en) * | 2013-01-25 | 2015-12-02 | Rigel Pharmaceuticals, Inc. | Compounds and methods for treating inflammatory bowel diseases |
| EP2970275B1 (en) | 2013-03-14 | 2018-05-09 | Rigel Pharmaceuticals, Inc. | Protein kinase c inhibitors and uses thereof |
| US20160159774A1 (en) * | 2014-12-05 | 2016-06-09 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
| WO2016100452A2 (en) * | 2014-12-17 | 2016-06-23 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
| WO2017007658A1 (en) * | 2015-07-07 | 2017-01-12 | Rigel Pharmaceuticals, Inc. | A combination for immune mediated cancer treatment |
| US20190060311A1 (en) * | 2017-08-24 | 2019-02-28 | Aclaris Therapeutics, Inc. | Compositions and methods for treatment of vitiligo |
| ES2925450T3 (es) * | 2017-11-06 | 2022-10-18 | Bristol Myers Squibb Co | Compuestos de isofuranona útiles como inhibidores de HPK1 |
| JP2021524458A (ja) * | 2018-05-24 | 2021-09-13 | アストラゼネカ・アクチエボラーグＡｓｔｒａｚｅｎｅｃａ Ａｋｔｉｅｂｏｌａｇ | ５−（（５−メチル−２−（（３，４，５−トリメチルフェニル）アミノ）ピリミジン−４−イル）アミノ）−ベンゾ［ｄ］オキサゾール−２（３Ｈ）−オンのフマル酸塩 |
| WO2020092015A1 (en) | 2018-11-02 | 2020-05-07 | University Of Rochester | Therapeutic mitigation of epithelial infection |
| CN110078633B (zh) * | 2019-05-24 | 2021-05-11 | 爱斯特（成都）生物制药股份有限公司 | 一种4-氟-3-甲氧基-5-甲基苯胺盐酸盐制备方法 |
| AU2021280113B2 (en) * | 2020-05-29 | 2023-12-21 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | Pyrimidine compound as AXL inhibitor |
| KR20250053739A (ko) * | 2023-10-13 | 2025-04-22 | 주식회사유한양행 | 7,7-다이메틸푸로[3,4-b]피리딘-5(7H)-온 유도체 또는 이의 염 및 이를 포함하는 약학 조성물 |
| WO2025109026A1 (en) * | 2023-11-21 | 2025-05-30 | Intervet International B.V. | Process for the preparation of 4-fluoro-3-methoxyaniline |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166452A (en) | 1976-05-03 | 1979-09-04 | Generales Constantine D J Jr | Apparatus for testing human responses to stimuli |
| US4256108A (en) | 1977-04-07 | 1981-03-17 | Alza Corporation | Microporous-semipermeable laminated osmotic system |
| US4265874A (en) | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
| US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
| US4738851A (en) | 1985-09-27 | 1988-04-19 | University Of Iowa Research Foundation, Inc. | Controlled release ophthalmic gel formulation |
| US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
| US4882150A (en) | 1988-06-03 | 1989-11-21 | Kaufman Herbert E | Drug delivery system |
| US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
| US5521222A (en) | 1989-09-28 | 1996-05-28 | Alcon Laboratories, Inc. | Topical ophthalmic pharmaceutical vehicles |
| ATE107176T1 (de) | 1989-12-04 | 1994-07-15 | Searle & Co | System zur transdermalen albuterol applikation. |
| US5077033A (en) | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
| EP0495421B1 (en) | 1991-01-15 | 1996-08-21 | Alcon Laboratories, Inc. | Use of carrageenans in topical ophthalmic compositions |
| US5352456A (en) | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
| JPH07502219A (ja) | 1991-12-18 | 1995-03-09 | ミネソタ マイニング アンド マニュファクチャリング カンパニー | 多重層型バリアー構造体 |
| ATE132381T1 (de) | 1992-01-29 | 1996-01-15 | Voelkl Franz Ski | Ballspielschläger, insbesondere tennisschläger |
| IL114193A (en) | 1994-06-20 | 2000-02-29 | Teva Pharma | Ophthalmic pharmaceutical compositions based on sodium alginate |
| ES2094688B1 (es) | 1994-08-08 | 1997-08-01 | Cusi Lab | Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion. |
| US5700904A (en) | 1995-06-07 | 1997-12-23 | Eli Lilly And Company | Preparation of an acylated protein powder |
| GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| IT1283911B1 (it) | 1996-02-05 | 1998-05-07 | Farmigea Spa | Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo |
| US5800807A (en) | 1997-01-29 | 1998-09-01 | Bausch & Lomb Incorporated | Ophthalmic compositions including glycerin and propylene glycol |
| US6261547B1 (en) | 1998-04-07 | 2001-07-17 | Alcon Manufacturing, Ltd. | Gelling ophthalmic compositions containing xanthan gum |
| US6197934B1 (en) | 1998-05-22 | 2001-03-06 | Collagenesis, Inc. | Compound delivery using rapidly dissolving collagen film |
| GB0016877D0 (en) * | 2000-07-11 | 2000-08-30 | Astrazeneca Ab | Chemical compounds |
| TWI329105B (en) * | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| CN103169708B (zh) | 2002-07-29 | 2018-02-02 | 里格尔药品股份有限公司 | 用2,4‑嘧啶二胺化合物治疗或者预防自体免疫性疾病的方法 |
| US7122542B2 (en) | 2003-07-30 | 2006-10-17 | Rigel Pharmaceuticals, Inc. | Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| US7449458B2 (en) | 2005-01-19 | 2008-11-11 | Rigel Pharmaceuticals, Inc. | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| US20060270694A1 (en) * | 2005-05-03 | 2006-11-30 | Rigel Pharmaceuticals, Inc. | JAK kinase inhibitors and their uses |
| CN101282945A (zh) * | 2005-06-08 | 2008-10-08 | 里格尔药品股份有限公司 | 抑制jak途径的组合物和方法 |
| US20070203161A1 (en) * | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
| US8393954B2 (en) | 2006-12-29 | 2013-03-12 | Cfph, Llc | Top performers |
| US8456526B2 (en) * | 2006-08-25 | 2013-06-04 | Sportvision, Inc. | Video effect using movement within an image |
| WO2008118822A1 (en) * | 2007-03-23 | 2008-10-02 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
| WO2009063240A1 (en) * | 2007-11-16 | 2009-05-22 | Arrow Therapeutics Limited | 2,4-diaminopyrimidine derivatives useful as inhibitors of aurora kinase |
| HRP20151325T1 (hr) * | 2009-01-23 | 2016-01-01 | Rigel Pharmaceuticals, Inc. | Pripravci i postupci za inhibiciju jak puta |
| WO2012015972A1 (en) * | 2010-07-28 | 2012-02-02 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
| US8637038B2 (en) * | 2011-04-12 | 2014-01-28 | Rigel Pharmaceuticals, Inc. | Methods for inhibiting allograft rejection |
-
2011
- 2011-07-27 WO PCT/US2011/045609 patent/WO2012015972A1/en not_active Ceased
- 2011-07-27 EA EA201390015A patent/EA201390015A1/ru unknown
- 2011-07-27 CN CN201180036682.6A patent/CN103201280B/zh not_active Expired - Fee Related
- 2011-07-27 US US13/192,344 patent/US8343954B2/en active Active
- 2011-07-27 RU RU2015122016A patent/RU2672100C2/ru active
- 2011-07-27 MX MX2013000757A patent/MX347331B/es active IP Right Grant
- 2011-07-27 DK DK11745858.8T patent/DK2598500T3/da active
- 2011-07-27 BR BR112013001632-9A patent/BR112013001632B1/pt not_active IP Right Cessation
- 2011-07-27 KR KR1020137004970A patent/KR101937495B1/ko not_active Expired - Fee Related
- 2011-07-27 JP JP2013521954A patent/JP6073221B2/ja not_active Expired - Fee Related
- 2011-07-27 AU AU2011282742A patent/AU2011282742B2/en not_active Ceased
- 2011-07-27 CA CA2804199A patent/CA2804199C/en active Active
- 2011-07-27 ES ES11745858T patent/ES2880622T3/es active Active
- 2011-07-27 PT PT117458588T patent/PT2598500T/pt unknown
- 2011-07-27 PL PL11745858T patent/PL2598500T3/pl unknown
- 2011-07-27 EP EP11745858.8A patent/EP2598500B1/en active Active
- 2011-07-28 AR ARP110102733A patent/AR082408A1/es active IP Right Grant
- 2011-07-28 TW TW100126853A patent/TWI582090B/zh not_active IP Right Cessation
-
2012
- 2012-11-26 US US13/685,433 patent/US9067925B2/en not_active Ceased
- 2012-12-25 IL IL223855A patent/IL223855A/en active IP Right Grant
-
2013
- 2013-01-15 ZA ZA2013/00388A patent/ZA201300388B/en unknown
- 2013-01-18 MX MX2020009397A patent/MX2020009397A/es unknown
-
2015
- 2015-05-29 US US14/725,932 patent/US9611260B2/en not_active Expired - Fee Related
- 2015-10-20 US US14/918,353 patent/USRE47396E1/en active Active
-
2016
- 2016-11-14 JP JP2016221423A patent/JP2017061518A/ja not_active Withdrawn
-
2017
- 2017-02-22 US US15/439,705 patent/US9920041B2/en active Active
-
2018
- 2018-02-08 US US15/892,224 patent/US10479783B2/en active Active
-
2019
- 2019-10-17 US US16/656,461 patent/US11174251B2/en active Active
-
2020
- 2020-09-02 AR ARP200102456A patent/AR119882A2/es unknown
-
2021
- 2021-10-05 US US17/494,370 patent/US20220024907A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013536179A5 (enExample) | ||
| RU2015122016A (ru) | Композиции и способы ингибирования пути jak | |
| US11306088B2 (en) | CXCR4 inhibitors and uses thereof | |
| ES2622493T3 (es) | Composiciones y métodos para la inhibición de la ruta de JAK | |
| JP6553632B2 (ja) | Ｂｅｔブロモドメイン阻害剤としてのテトラヒドロキノリン組成物 | |
| KR20220042429A (ko) | Rip1 억제 화합물 및 그를 제조 및 사용하는 방법 | |
| EP3071205A1 (en) | Benzopiperazine compositions as bet bromodomain inhibitors | |
| RU2008122070A (ru) | Аминопиридины, используемые в качестве ингибиторов киназ | |
| JP2019533687A5 (enExample) | ||
| JP7304892B2 (ja) | 抗増殖性化合物およびその使用 | |
| JP2019510025A (ja) | ピリミジンおよびそのバリアント、ならびにそのための使用 | |
| WO2024054603A1 (en) | Heterobifunctional compounds and methods of treating disease | |
| TW202317560A (zh) | Ｃｄｋ２抑制劑及其使用方法 | |
| CN115677616B (zh) | 大环磺酰胺类化合物及其制备方法和医药用途 | |
| WO2024054955A1 (en) | Heterobifunctional compounds and methods of treating disease | |
| TW202321228A (zh) | 苯並二噁烷類化合物、其製備方法與應用 | |
| WO2024264070A2 (en) | Akt inhibitors |